Strategies for Treatment of Thyroid Cancer

被引:4
作者
Yadav, Deepika [1 ]
Sharma, Pramod Kumar [1 ]
Malviya, Rishabha [1 ]
Mishra, Prem Shankar [1 ]
机构
[1] Galgotias Univ, Sch Med & Allied Sci, Dept Pharm, Greater Noida, Uttar Pradesh, India
关键词
Thyroid cancer; radioactive iodine; molecular therapy; ablation treatment; thyroidectomy; novel target therapy; RET/PTC ONCOGENE ACTIVATION; PHASE-II TRIAL; RET PROTOONCOGENE; PAPILLARY CARCINOMAS; CURRENT DIAGNOSIS; KINASE INHIBITOR; HIGH-FREQUENCY; RAS; REARRANGEMENTS; TUMORS;
D O I
10.2174/1389450124666230222093308
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
More people are diagnosed with thyroid cancer than any other endocrine tumor. Differentiated thyroid cancer is often treated by removing the thyroid gland (thyroidectomy), iodizing radiation, or inhibiting thyroid stimulating hormone (TSH). Advanced thyroid carcinomas are notoriously resistant to chemotherapy, thus the pursuit of alternative treatments is vital. The best methods for treating individuals with advanced nonmedullary and medullary thyroid carcinomas are discussed in this post. Numerous tyrosine kinase inhibitors and antiangiogenic inhibitors, two types of novel target therapy, have shown promise in studies for individuals with thyroid cancer. Both the positive and unfavourable outcomes of clinical studies of these drugs were addressed. The findings presented here are encouraging, but more study is required to establish whether or not this method is effective in the treatment of thyroid cancer.
引用
收藏
页码:406 / 415
页数:10
相关论文
共 50 条
  • [31] Current treatment strategies for papillary thyroid microcarcinoma
    Weber, Theresia
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2021, 14 (04): : 140 - 144
  • [32] Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities
    Zhang, Lizhuo
    Feng, Qingqing
    Wang, Jiafeng
    Tan, Zhuo
    Li, Qinglin
    Ge, Minghua
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (04):
  • [33] Targeted therapy in thyroid cancer: Towards a treatment card
    Lkhoyaali, S.
    Benhmida, S.
    Elhaj, M. Ait
    Layachi, M.
    Bensouda, Y.
    Errihani, H.
    PATHOLOGIE BIOLOGIE, 2015, 63 (01): : 1 - 6
  • [34] Role of Thyroidectomy in Early Diagnosis and Treatment of Thyroid Cancer
    Ipekci, Fuat
    Engin, Omer
    Inani, Oguzhan
    Akyildiz, Nejat
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2012, 3 (03) : 283 - 285
  • [35] Radiopharmaceuticals: A New Vista for Diagnosis and Treatment of Thyroid Cancer
    Vernekar, Siddhi
    Budha, Roja Rani
    Alavala, Rajasekhar Reddy
    CURRENT RADIOPHARMACEUTICALS, 2024, 17 (02) : 148 - 162
  • [36] Treatment Patterns of Aging Americans With Differentiated Thyroid Cancer
    Park, Henry S.
    Roman, Sanziana A.
    Sosa, Julie Ann
    CANCER, 2010, 116 (01) : 20 - 30
  • [37] KINASE INHIBITORS IN THE TREATMENT OF THYROID CANCER: INSTITUTIONAL EXPERIENCE
    Pesorda, Matea
    Kuna, Sanja Kusacic
    Huic, Drazen
    Herceg, Davorin
    Despot, Marija
    Samardzic, Tatjana
    Gnjidic, Milena
    Belev, Borislav
    ACTA CLINICA CROATICA, 2020, 59 : 73 - 80
  • [38] Optimizing treatment and follow-up of thyroid cancer
    Shah, Jatin P.
    Nixon, Iain
    SALUD I CIENCIA, 2012, 19 (03): : 237 - 241
  • [39] Tailoring the approach to radioactive iodine treatment in thyroid cancer
    Mayson, Sarah E.
    Chan, Christine M.
    Haugen, Bryan R.
    ENDOCRINE-RELATED CANCER, 2021, 28 (10) : T125 - T140
  • [40] Treatment Variation in Older Adults With Differentiated Thyroid Cancer
    Sutton, Whitney
    Canner, Joseph K.
    Segev, Dorry L.
    Zeiger, Martha A.
    Mathur, Aarti
    JOURNAL OF SURGICAL RESEARCH, 2020, 254 : 154 - 164